Ryan, C. E., Ren, Y., Tyekucheva, S., Arnason, J. E., Boruchov, A. M., Jacobson, C. A., . . . Davids, M. S. Long‐term results of a phase 1/1b study of ibrutinib plus umbralisib for relapsed/refractory chronic lymphocytic leukemia. Wiley.
Chicago Style (17th ed.) CitationRyan, Christine E., et al. Long‐term Results of a Phase 1/1b Study of Ibrutinib Plus Umbralisib for Relapsed/refractory Chronic Lymphocytic Leukemia. Wiley.
MLA (9th ed.) CitationRyan, Christine E., et al. Long‐term Results of a Phase 1/1b Study of Ibrutinib Plus Umbralisib for Relapsed/refractory Chronic Lymphocytic Leukemia. Wiley.
Warning: These citations may not always be 100% accurate.